Leonard Rickey Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,323
Closed -$254K 66
2020
Q2
$254K Sell
4,323
-1,088
-20% -$65.1K 0.17% 54
2020
Q1
$302K Sell
5,411
-453
-8% -$27.7K 0.23% 40
2019
Q4
$376K Buy
5,864
+1,404
+31% +$80.4K 0.23% 42
2019
Q3
$226K Buy
4,460
+14
+0.3% +$658 0.15% 68
2019
Q2
$202K Buy
+4,446
New +$207K 0.14% 72

Other funds holding BMY

Leonard Rickey Investment Advisors's BMY Position: Q3 2020 in Review

Leonard Rickey Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 4,323 shares — an estimated $254K sold.

Leonard Rickey Investment Advisors first reported a position in BMY in Q2 2019 and held it in 5 quarters. The position peaked at $376K in Q4 2019. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Leonard Rickey Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Leonard Rickey Investment Advisors sold 4,323 Bristol-Myers Squibb shares in Q3 2020, an estimated $254K.
  • Leonard Rickey Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 5 quarters.
  • Leonard Rickey Investment Advisors's Bristol-Myers Squibb position peaked at $376K in Q4 2019.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Leonard Rickey Investment Advisors's 13F filing for Q3 2020, filed 16 Oct 2020.